Segments - Aflatoxicosis Treatment Market by Product Type (Diagnostic Tools, Therapeutic Interventions, and Preventive Measures), Application (Food & Feed Safety and Healthcare), End-user (Healthcare Facilities, Agriculture & Food Industry, Research & Academic Institutions), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2024 – 2032
The global aflatoxicosis treatment market size was USD 284.6 Million in 2023 and is likely to reach USD 398.1 Million by 2032, expanding at a CAGR of 3.8% during 2024–2032. The market growth is attributed to its growing awareness among consumers and increasing globalization of food supply chain.
Aflatoxicosis is a form of poisoning that results from the ingestion of aflatoxins, which are toxic metabolites produced by certain species of fungi, primarily Aspergillus flavus and Aspergillus parasiticus. These toxins contaminate a variety of agricultural products, especially grains and nuts, during pre-harvest, post-harvest, or storage periods. Therapeutic interventions for aflatoxicosis primarily focus on supportive care products such as intravenous fluids, anti-emetics, and pain management medications.
Nutritional supplements, including vitamins and minerals, particularly antioxidants, are also used to help mitigate aflatoxin damage. Hepatoprotective agents, which encompass both pharmaceuticals and herbal supplements, are crucial in supporting liver health. Preventive measures are equally important and include the use of agricultural products like fungicides, biocontrol agents, and improved storage solutions to prevent aflatoxin contamination in crops. Additionally, food safety testing technologies and services play a vital role in monitoring and controlling aflatoxin levels in food supplies, ensuring public health safety.
AI-powered tools significantly improve the accuracy and speed of detecting aflatoxins in food products and biological samples. Machine learning algorithms analyze large datasets from food safety tests, identifying patterns and anomalies that might indicate contamination. AI-driven diagnostic devices provide rapid, real-time results, enabling quicker responses to aflatoxin outbreaks and reducing the risk of widespread exposure.
Growing awareness among consumers, healthcare professionals, and governments about the dangers of aflatoxins and the importance of food safety is driving the global market. Moreover, the increasing globalization of food supply chain is expected to propel the global market. This globalization drives the need for robust testing and treatment solutions to ensure food safety across borders, fueling the market.
High cost of the advanced technology is expected to impede the global market. The implementation of advanced diagnostic tools and treatment solutions often comes with high costs. Many small-scale farmers, particularly in developing regions, cannot afford these technologies. This economic barrier limits the widespread adoption of state-of-the-art aflatoxin management practices.
The use of biocontrol agents, such as non-toxigenic strains of Aspergillus species, offers a sustainable and environmentally friendly approach to reducing aflatoxin contamination in crops. Biopesticides and other natural products are gaining traction as effective alternatives to chemical fungicides, providing safer options for farmers. Advances in genetic engineering develops aflatoxin-producing fungi resistant crops. Genetically modified organisms (GMOs) are designed to resist fungal infection, reducing the risk of contamination and ensuring safer food supplies.
The market report includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Aflatoxicosis Treatment Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2023 |
Historic Data |
2017–2022 |
Forecast Period |
2024–2032 |
Segmentation |
Product Type (Diagnostic Tools, Therapeutic Interventions, and Preventive Measures), Application (Food & Feed Safety and Healthcare), and End-user (Healthcare Facilities, Agriculture & Food Industry, Research & Academic Institutions) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
Key Players Covered in the Report |
Abbott Laboratories; Glaxo Smith Kline; Johnson and Johnson; Pfizer Inc.; Sanofi; and Zydus Cadilla. |
In terms of region, the global aflatoxicosis treatment market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. Asia Pacific dominates the global market in 2023 owing to the high incidence of aflatoxin contamination. Asia Pacific, particularly countries like China, India, and Southeast Asian nations, has a high incidence of aflatoxin contamination due to favorable climatic conditions for the growth of aflatoxin-producing fungi.
The market in North America is projected to grow at a significant pace in the years to come owing to the advanced healthcare infrastructure. North America boasts advanced healthcare infrastructure and diagnostic capabilities, enabling efficient detection and management of aflatoxicosis cases. Furthermore, the high consumer awareness in North America is expected to drive the regional market.
Based on product type, the aflatoxicosis treatment market is divided into diagnostic tools, therapeutic interventions, and preventive measures. The preventive measures segment held the largest share in the global market in 2023 owing to the widespread application in agriculture. Preventive measures, such as fungicides, biocontrol agents, and improved storage solutions, are crucial in the agricultural sector to prevent aflatoxin contamination at the source. Since aflatoxins primarily affect crops such as corn, peanuts, and tree nuts, significant resources are allocated to prevent contamination during cultivation, harvest, and storage.
The diagnostic tools segment is anticipated to grow at a substantial CAGR during the forecast period due to the increasing need for early detection. Early and accurate detection of aflatoxins in food and feed products is crucial for preventing widespread contamination and ensuring food safety. Furthermore, the higher demand for transparency and assurance regarding the absence of contaminants such as aflatoxins is driving the segment.
On the basis of application, the global market is segregated into food & feed safety and healthcare. The food & feed safety segment is anticipated to register a considerable CAGR in over the predicted period owing to the rising prevalence of aflatoxin contamination in food & feed. Moreover, the increasing consumer awareness and demand is expected to boost the segment during the forecast period.
The healthcare segment is projected to register a robust growth rate during the assessment years due to the management of aflatoxicosis cases. Healthcare institutions are involved in public health surveillance efforts to monitor aflatoxin-related illnesses and outbreaks, propelling the segment. Clinical trials, epidemiological studies, and laboratory research contribute to advancements in aflatoxin management, leading to improved diagnostics, therapies, and public health interventions.
On the basis of end-user, the aflatoxicosis treatment market is segmented into healthcare facilities, agriculture & food industry, research & academic institutions. The agriculture & food industry segment register a robust growth rate in 2023 due to the primary focus on prevention. Furthermore, the increasing technological advancements and adoption is expected to drive the segment during the forecast period.
The aflatoxicosis treatment market has been segmented on the basis of
Key players competing in the global aflatoxicosis treatment market are Abbott Laboratories; Glaxo Smith Kline; Johnson and Johnson; Pfizer Inc.; Sanofi; and Zydus Cadilla.